15/05/2006 | Press Releases
Melbourne based biotechnology company Hatchtech Pty Ltd will proceed with full development of a lead head lice control candidate. The company will appoint a European laboratory to commence the pre-clinical and toxicity testing in readiness for the first human trials later this year.